{
  "node": {
    "slug": "chronic-kidney-disease",
    "network": "ckd_trials",
    "title": "Chronic kidney disease trials",
    "description": "Recruiting chronic kidney disease studies from ClinicalTrials.gov, with eligibility criteria structured for private pre-screening."
  },
  "disclaimer": "Demo node, not a real trial site; pre-screening only, not medical advice.",
  "source": {
    "name": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/",
    "retrieved": "2026-11-16",
    "modified": "Fields selected and summaries shortened by ChartStays; eligibility criteria structured and coded. Each study links to its authoritative ClinicalTrials.gov record."
  },
  "studies": [
    {
      "nct_id": "NCT06725810",
      "title": "Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease",
      "status": "RECRUITING",
      "conditions": [
        "Chronic Kidney Disease Associated Anemia"
      ],
      "phases": [
        "PHASE4"
      ],
      "sponsor": "Shanghai Zhongshan Hospital",
      "summary": "The CANNON trial is a prospective, open-label, randomized, multicenter study designed to investigate rational hemoglobin target value in patients with anemia of non-dialysis chronic kidney disease treated with enarodustat. Eligible patients are randomly assigned 1:1 to the high-hemoglobin target group （hemoglobin of 13 g/dl）and low-hemoglobin target group （hemoglobin of 11 g/dl）and administered w…",
      "url": "https://clinicaltrials.gov/study/NCT06725810",
      "last_update_posted": "2025-07-28",
      "criteria": "./criteria/NCT06725810.json",
      "logistics": "./logistics/NCT06725810.json",
      "structured_criteria": 4,
      "free_text_criteria": 25
    },
    {
      "nct_id": "NCT04819217",
      "title": "Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease",
      "status": "RECRUITING",
      "conditions": [
        "CKD"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "National Taiwan University Hospital",
      "summary": "In patients with chronic kidney disease (CKD), uremic toxins accumulate when kidney function declines. Those uremic toxins had a greater affinity to circulating proteins are called \"protein bound uremic toxins, PBUT.\" Apart from traditional small or middle molecule uremic toxins, the PBUTs can be rarely eliminated using traditional renal replacement therapy, even using high flux dialysis modaliti…",
      "url": "https://clinicaltrials.gov/study/NCT04819217",
      "last_update_posted": "2025-07-18",
      "criteria": "./criteria/NCT04819217.json",
      "logistics": "./logistics/NCT04819217.json",
      "structured_criteria": 8,
      "free_text_criteria": 12
    },
    {
      "nct_id": "NCT07851454",
      "title": "Walnuts for Cardiorenal Protection in Adults With Chronic Kidney Disease",
      "status": "RECRUITING",
      "conditions": [
        "CKD - Chronic Kidney Disease",
        "Renal Function",
        "Cardiovascular Biomarkers"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "Institut Investigacio Sanitaria Pere Virgili",
      "summary": "To date, no rigorous randomized controlled trials have demonstrated a protective effect of daily moderate walnut consumption on kidney function or chronic kidney disease (CKD) progression in individuals with CKD. Objective: To determine the effect of walnut supplementation (30 g/day of raw walnuts) within a Mediterranean diet (MedDiet) based dietary counseling program, compared with the same MedD…",
      "url": "https://clinicaltrials.gov/study/NCT07851454",
      "last_update_posted": "2026-10-01",
      "criteria": "./criteria/NCT07851454.json",
      "logistics": "./logistics/NCT07851454.json",
      "structured_criteria": 4,
      "free_text_criteria": 11
    },
    {
      "nct_id": "NCT06923709",
      "title": "Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease",
      "status": "RECRUITING",
      "conditions": [
        "Chronic Kidney Disease(CKD)",
        "Proteinuria"
      ],
      "phases": [
        "PHASE2"
      ],
      "sponsor": "Odense University Hospital",
      "summary": "This is a randomized, placebo-controlled, double-blinded crossover trial testing the effects of amiloride in patients with chronic kidney disease (CKD) and proteinuria. In CKD with proteinuria, there is aberrant filtration of serine proteases and complement precursors into the tubular lumen. The interaction of these factors leads to proinflammatory complement activation, which may promote inflamm…",
      "url": "https://clinicaltrials.gov/study/NCT06923709",
      "last_update_posted": "2025-04-11",
      "criteria": "./criteria/NCT06923709.json",
      "logistics": "./logistics/NCT06923709.json",
      "structured_criteria": 6,
      "free_text_criteria": 25
    },
    {
      "nct_id": "NCT07835828",
      "title": "Optimised Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and Cardiovascular Disease",
      "status": "RECRUITING",
      "conditions": [
        "Chronic Kidney Disease",
        "Heart Failure With Preserved Ejection Fraction (HFPEF)",
        "Cardiovascular Diseases"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "Odense University Hospital",
      "summary": "The goal of this clinical trial is to investigate whether care in a specialised Cardio-Renal Clinic can improve the health of people living with both cardiovascular disease and chronic kidney disease. The clinic brings together expertise in heart and kidney disease and provides structured treatment based on current clinical guidelines. The main research questions are: * After one year, does care…",
      "url": "https://clinicaltrials.gov/study/NCT07835828",
      "last_update_posted": "2026-10-15",
      "criteria": "./criteria/NCT07835828.json",
      "logistics": "./logistics/NCT07835828.json",
      "structured_criteria": 3,
      "free_text_criteria": 9
    }
  ]
}
